What is Evommune 's common stock?

Evommune (EVMN) reported common stock of 220M in Q1 2026.

What is the long-term trend for Evommune 's common stock?

Over 2 years (2020 to 2025), Evommune 's common stock has grown at a 48.3% compound annual growth rate (CAGR), from 100M to 220M.

What does common stock mean?

The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Evommune EVMN Common Stock

Common Stock at other companies

Bausch + LombBLCO

$0—

Perrigo CompanyPRGO

10B0.0%

Hims & Hers HealthHIMS

$23K+4.5%

Other financials

Income statement

See full

Revenue$1.6M+3.5%

Gross profit$961.1K+10.9%

Operating income-$682.8K-2,027%

Net income-$7.0M-5,414%

EPS (diluted)-$0.36-1,700%

Balance sheet

See full

Cash & equivalents$1.1M+401%

Total debt$2.0M—

Total equity-$4.5M-3,048%

Total assets$7.2M—

Cash flow

See full

Operating cash flow-$424.6K-341%

CapEx$1.0-99.8%

Free cash flow-$2.7M-4,996%

Valuation

See full

Market cap$848.59M+39.5%

Enterprise value$849.52M—

P/S127.3×—

Profitability

See full

Gross margin53.7%—

Operating margin-30.7%—

Net margin-90.1%—

Returns & leverage

See full

Return on equity275.7%—

Debt / equity1.4×—

Current ratio1.2×—

Where this comes from

Reported directly by Evommune in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Evommune 's common stock?: Evommune (EVMN) reported common stock of 220M in Q1 2026.
What is the long-term trend for Evommune 's common stock?: Over 2 years (2020 to 2025), Evommune 's common stock has grown at a 48.3% compound annual growth rate (CAGR), from 100M to 220M.
What does common stock mean?: The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).